Quantification of muscle pathology in infantile Pompe disease

被引:19
|
作者
Schaenzer, Anne [1 ]
Kaiser, Ann-Kathrin [1 ]
Muehlfeld, Christian [2 ]
Kulessa, Martin [1 ]
Paulus, Werner [3 ]
von Pein, Harald [4 ]
Rohrbach, Marianne [5 ]
Viergutz, Lara [1 ]
Mengel, Eugen [6 ]
Marquardt, Thorsten [7 ]
Neubauer, Bernd [8 ]
Acker, Till [1 ]
Hahn, Andreas [8 ]
机构
[1] Justus Liebig Univ, Inst Neuropathol, Giessen, Germany
[2] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany
[3] Univ Med Ctr, Inst Neuropathol, Munster, Germany
[4] Univ Med Ctr JGU Univ, Dept Neuropathol, Mainz, Germany
[5] Univ Childrens Hosp, Childrens Res Ctr, Div Metab, Zurich, Switzerland
[6] Univ Med Ctr JGU Univ, Villa Metab, Mainz, Germany
[7] Westfal Wilhelms Univ, Dept Pediat, Munster, Germany
[8] Justus Liebig Univ, Dept Child Neurol, Giessen, Germany
关键词
Pompe disease; Glycogen storage disease type II; Enzyme replacement therapy; Lysosomal storage disease; Acid maltase deficiency; Autophagy; ENZYME REPLACEMENT THERAPY; ACID ALPHA-GLUCOSIDASE; CLASSIC INFANTILE; CRIM STATUS; AUTOPHAGY;
D O I
10.1016/j.nmd.2016.10.010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The effects of enzyme replacement therapy (ERT) in infantile Pompe disease are variable, necessitating the identification of biomarkers to assess the severity of disease and response to ERT. The aims of this study were to investigate whether quantification of muscle pathology in infantile Pompe disease prior to and during ERT is feasible at the light microscope, and to develop a score that summarizes the degree of muscle pathology in a comprehensive manner from PAS-stained resin sections alone. We, therefore, determined glycogen load, extent of muscle fibre disruption, and amount of autophagic vacuoles in resin-embedded muscle biopsy specimens from 11 infantile Pompe patients and 2 with early childhood phenotype by quantitative methods, correlated the findings with ultrastructural analyses, compared PAS-stained resin sections with conventional PAS-stained cryosections, and related the quantified degree of muscle damage from infantile patients to the effects of ERT. Comparison of electron and light microscopic findings demonstrated that important alterations of skeletal muscle morphology can also be depicted by examining PAS stained resin sections. Infantile patients with good response to ERT had lower muscle pathology score values prior to and during ERT than those with moderate and poor response, but the number of tissue samples available for evaluation was limited. These findings suggest that quantification of muscle pathology by analysing PAS stained resin sections is in principle feasible and useful to monitor disease progression and therapy response. These results have to be validated by investigating a larger group of patients. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:141 / 152
页数:12
相关论文
共 50 条
  • [1] Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
    Prater, Sean N.
    Patel, Trusha T.
    Buckley, Anne F.
    Mandel, Hanna
    Vlodavski, Eugene
    Banugaria, Suhrad G.
    Feeney, Erin J.
    Raben, Nina
    Kishnani, Priya S.
    ORPHANET JOURNAL OF RARE DISEASES, 2013, 8
  • [2] Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
    Sean N Prater
    Trusha T Patel
    Anne F Buckley
    Hanna Mandel
    Eugene Vlodavski
    Suhrad G Banugaria
    Erin J Feeney
    Nina Raben
    Priya S Kishnani
    Orphanet Journal of Rare Diseases, 8
  • [3] Analyzing immune cell infiltrates in skeletal muscle of infantile-onset Pompe disease using bioinformatics and machine learning
    Zhang, Jingfei
    Lin, Xinyu
    Yin, Lan
    Song, Yue
    Chen, Xinglu
    Zhu, Yingchuan
    Jiang, Wenhao
    Lu, Yilu
    Ma, Yongxin
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [4] Autophagy in skeletal muscle: implications for Pompe disease
    Shea, L.
    Raben, N.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 : S42 - S47
  • [5] The emerging phenotype of long-term survivors with infantile Pompe disease
    Prater, Sean N.
    Banugaria, Suhrad G.
    DeArmey, Stephanie M.
    Botha, Eleanor G.
    Stege, Erin M.
    Case, Laura E.
    Jones, Harrison N.
    Phornphutkul, Chanika
    Wang, Raymond Y.
    Young, Sarah P.
    Kishnani, Priya S.
    GENETICS IN MEDICINE, 2012, 14 (09) : 800 - 810
  • [6] Hearing loss in infantile Pompe's disease and determination of underlying pathology in the knockout mouse
    Kamphoven, JHJ
    de Ruiter, MM
    Winkel, LPF
    Van den Hout, HMP
    Bijman, J
    De Zeeuw, CI
    Hoeve, HL
    Van Zanten, BA
    Van der Ploeg, AT
    Reuser, AJJ
    NEUROBIOLOGY OF DISEASE, 2004, 16 (01) : 14 - 20
  • [7] A new phenotype of infantile-onset Pompe disease
    Nascimento, Andres
    Villalobos-Pinto, Enrique
    REVISTA DE NEUROLOGIA, 2018, 66 (04) : 121 - 124
  • [8] Clinical guidelines for infantile-onset Pompe disease
    Pascual-Pascual, Samuel I.
    Nascimento, Andres
    Fernandez-Llamazares, Cecilia M.
    Medrano-Lopez, Constancio
    Villalobos-Pinto, Enrique
    Martinez-Moreno, Mercedes
    Ley, Miriam
    Manrique-Rodriguez, Silvia
    Blasco-Alonso, Javier
    REVISTA DE NEUROLOGIA, 2016, 63 (06) : 269 - 279
  • [9] Transcriptional response to GAA deficiency (Pompe disease) in infantile-onset patients
    Palermo, A. T.
    Palmer, R. E.
    So, K. S.
    Oba-Shinjo, S. M.
    Zhang, M.
    Richards, B.
    Madhiwalla, S. T.
    Finn, P. F.
    Hasegawa, A.
    Ciociola, K. M.
    Pescatori, M.
    McVie-Wylie, A. J.
    Mattaliano, R. J.
    Madden, S. L.
    Marie, S. K. N.
    Klinger, K. W.
    Pomponio, R. J.
    MOLECULAR GENETICS AND METABOLISM, 2012, 106 (03) : 287 - 300
  • [10] Lentiviral gene therapy with IGF2-tagged GAA normalizes the skeletal muscle proteome in murine Pompe disease
    Liang, Qiushi
    Pijnenburg, Joon M.
    Rijkers, Erikjan
    Vulto, Arnold G.
    van der Ploeg, Ans T.
    van Til, Niek P.
    Vlaar, Eva C.
    Demmers, Jeroen A. A.
    Pijnappel, W. W. M. Pim
    JOURNAL OF PROTEOMICS, 2024, 291